| Bioactivity | Etidocaine (EDC) is a long aminoamide local anesthetic[1]. |
| Invitro | IGL-EDC formulations can induce a significant increase in human fibroblasts survival[1]. Cell Viability Assay[1] Cell Line: |
| In Vivo | Etidocaine (spinal injection, 0.0075%, once) does not show postinjection neurologic deficit[2]. Animal Model: |
| Name | Etidocaine |
| CAS | 36637-18-0 |
| Formula | C17H28N2O |
| Molar Mass | 276.42 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Oliveira, et al. Sustained Release from Ionic-Gradient Liposomes Significantly Decreases ETIDOCAINE Cytotoxicity. Pharmaceutical research vol. 35, 12 229. 10 Oct. 2018. [2]. Langerman, L, et al. The partition coefficient as a predictor of local anesthetic potency for spinal anesthesia: evaluation of five local anesthetics in a mouse model. Anesthesia and analgesia vol. 79,3 (1994): 490-4. |